Based on model simulations (figure 10), the GADD45β-targeted therapy is suggested to be more sensitive than the NF-κB-targeted therapy as it can produce a greater suppression of MM cells than IKK inhibition when each are suppressed to the same degree. Here, GADD45B is linked to Miyoshi myopathy.